Pityriasis lichenoides chronica in a patient on tafasitamab and lenalidomide therapy for diffuse large B-cell lymphoma

Pityriasis lichenoides et varioliformis acuta in a patient treated with cevostamab

“…In that case, the authors posited that T-cell dysregulation due to altered B-cell response could explain the development of PLC. 6 In our case, the patient received a treatment specifically designed to alter T-cell behavior, which may align with this proposed mechanism of pathogenesis.…”